Acrux limited mail
Acrux Limited is a publicly listed company on the Australian Securities Exchange (ASX) that specializes in the development and commercialization of medical devices and pharmaceuticals. Here are some key points about Acrux Limited's mail:
- Headquarters: Acrux Limited is headquartered in Melbourne, Australia.
- Business: The company focuses on developing and commercializing medical devices and pharmaceuticals for various therapeutic areas, including pain management, wound care, and dermatology.
- Products: Acrux Limited has a portfolio of products, including the EMLA cream for topical anesthesia, the S-CANN spray for wound care, and the ACRUX-101 cream for skin conditions.
- Research and Development: The company invests heavily in research and development to identify new opportunities and improve existing products.
- Partnerships: Acrux Limited collaborates with other companies, research institutions, and government agencies to advance its products and technologies.
- Regulatory Approvals: The company's products have received regulatory approvals from various authorities, including the US FDA, the European Medicines Agency (EMA), and the Therapeutic Goods Administration (TGA) in Australia.
- Financials: Acrux Limited is a publicly listed company, and its financial performance is reported quarterly and annually. The company's financials can be accessed through the ASX website or the company's investor relations website.
If you're looking for specific information about Acrux Limited's mail, you may want to contact the company directly or visit their website. Here is the company's contact information:
Acrux Limited Level 2, 333 La Trobe Street Melbourne, VIC 3000 Australia Phone: +61 3 9602 8800 Fax: +61 3 9602 8899 Email: [email protected] Website: www.acrux.com